TCM Biotech International Corp. (TPEX:4169)
Taiwan
· Delayed Price · Currency is TWD 179.00
-2.00 (-1.10%)
At close: Dec 5, 2025
TCM Biotech International Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 10,570 | 3,419 | 3,437 | 1,502 | 1,819 | 1,713 | Upgrade
|
| Market Cap Growth | 198.83% | -0.52% | 128.87% | -17.43% | 6.17% | 62.78% | Upgrade
|
| Enterprise Value | 10,092 | 2,966 | 3,518 | 1,592 | 1,930 | 1,741 | Upgrade
|
| Last Close Price | 179.00 | 57.70 | 57.70 | 29.09 | 35.68 | 33.23 | Upgrade
|
| PE Ratio | 501.46 | 162.73 | 185.02 | 82.21 | 970.95 | 67.06 | Upgrade
|
| PS Ratio | 15.49 | 5.13 | 3.54 | 1.87 | 2.59 | 2.32 | Upgrade
|
| PB Ratio | 9.96 | 3.23 | 3.26 | 2.80 | 3.51 | 3.31 | Upgrade
|
| P/TBV Ratio | 9.99 | 3.24 | 3.28 | 2.85 | 3.60 | 3.41 | Upgrade
|
| P/FCF Ratio | 290.58 | 21.45 | - | 30.98 | 162.55 | 23.80 | Upgrade
|
| P/OCF Ratio | 261.91 | 20.42 | - | 28.74 | 118.66 | 22.87 | Upgrade
|
| EV/Sales Ratio | 14.79 | 4.45 | 3.63 | 1.98 | 2.75 | 2.36 | Upgrade
|
| EV/EBITDA Ratio | 226.46 | 103.67 | 89.02 | 38.95 | 117.57 | 34.58 | Upgrade
|
| EV/EBIT Ratio | - | 277.32 | 157.56 | 62.91 | 905.86 | 46.99 | Upgrade
|
| EV/FCF Ratio | 277.46 | 18.61 | - | 32.84 | 172.54 | 24.19 | Upgrade
|
| Debt / Equity Ratio | 0.04 | 0.04 | 0.11 | 0.29 | 0.31 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 0.88 | 1.33 | 2.71 | 3.60 | 8.66 | 2.49 | Upgrade
|
| Debt / FCF Ratio | 1.07 | 0.27 | - | 3.25 | 14.39 | 1.79 | Upgrade
|
| Asset Turnover | - | 0.53 | 0.89 | 0.95 | 0.88 | 0.96 | Upgrade
|
| Inventory Turnover | - | 1.99 | 2.44 | 1.79 | 1.67 | 1.82 | Upgrade
|
| Quick Ratio | 8.20 | 8.24 | 3.87 | 1.42 | 1.42 | 1.74 | Upgrade
|
| Current Ratio | 10.03 | 9.91 | 4.95 | 2.29 | 2.67 | 3.69 | Upgrade
|
| Return on Equity (ROE) | - | 1.99% | 2.33% | 3.46% | 0.36% | 4.97% | Upgrade
|
| Return on Assets (ROA) | - | 0.53% | 1.28% | 1.88% | 0.17% | 3.01% | Upgrade
|
| Return on Capital (ROIC) | - | 0.59% | 1.50% | 2.30% | 0.20% | 3.54% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.00% | 1.00% | 2.00% | 4.00% | 0.30% | 5.60% | Upgrade
|
| Earnings Yield | 0.20% | 0.61% | 0.54% | 1.22% | 0.10% | 1.49% | Upgrade
|
| FCF Yield | 0.34% | 4.66% | -1.21% | 3.23% | 0.61% | 4.20% | Upgrade
|
| Dividend Yield | 0.20% | 0.61% | 0.49% | 0.11% | - | 1.05% | Upgrade
|
| Payout Ratio | 98.05% | 80.10% | 8.71% | - | 903.20% | 73.59% | Upgrade
|
| Buyback Yield / Dilution | -0.87% | -11.37% | -8.03% | -0.89% | -0.42% | 0.03% | Upgrade
|
| Total Shareholder Return | -0.67% | -10.76% | -7.54% | -0.77% | -0.42% | 1.08% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.